Time efficacy of a single dose of montelukast on exercise‐induced asthma in children
- 14 December 2002
- journal article
- clinical trial
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 13 (6) , 434-437
Abstract
The aim of this study was to evaluate the timing of onset and the duration of action of a single oral‐dose treatment with montelukast in comparison to placebo on exercise‐induced asthma (EIA) in asthmatic children. Nineteen children (7–13 years) with stable asthma were evaluated. Patients undertook three consecutive treadmill exercise tests, respectively, 2, 12 and 24 h after a single‐dose administration. A double‐blind randomized, single‐dose, placebo‐controlled, crossover design was used. To assess bronchoconstriction after the exercise challenge, the maximal percentage fall in FEV1 (ΔFEV1) from the baseline value was considered. Two hours after dosing, ΔFEV1 was −15.33 ± 2.93 for placebo and −13.33 ± 2.03 for montelukast. At 12 h, ΔFEV1 was −18.69 ± 2.83 for placebo, −9.78 ± 1.85 for montelukast (p < 0.005). No difference was observed between placebo (ΔFEV1−10.21 ± 2.07) and montelukast (ΔFEV1−9.10 ± 2.02) at 24 h. Analysis of the degree of protection showed a significant efficacy of montelukast (p = 0.02) in comparison with placebo only at 12 h. Montelukast showed a significant protective effect 12 h after dosing, but no effect after 2 and 24 h. In mild asthmatics, the timing of administration of single dosage before exercise should be strictly considered in order to obtain the drug protective effects.Keywords
This publication has 15 references indexed in Scilit:
- Comparative effects of long-acting β2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthmaJournal of Allergy and Clinical Immunology, 2000
- Exercise-induced bronchoconstriction depends on exercise loadRespiratory Medicine, 2000
- Leukotriene Bronchoconstriction Induced by Allergen and ExerciseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Guidelines for Methacholine and Exercise Challenge Testing—1999: T his Official Statement of the American Thoracic Society Was Adopted by the ATS Board of Directors, July 1999American Journal of Respiratory and Critical Care Medicine, 2000
- Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 1999
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Single dose pharmacokinetics, safety and tolerability of MK‐0476, a new leukotriene D4‐receptor antagonist, in healthy volunteers.British Journal of Clinical Pharmacology, 1995
- Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adultsEuropean Respiratory Journal, 1993
- Original Articles: Efficacy and Duration of Action of Placebo Responses in the Prevention of Exercise-Induced Asthma in ChildrenJournal of Asthma, 1988
- Demonstration by placebo response in asthma by means of exercise testingJournal of Psychosomatic Research, 1973